Welcure Drugs & Pharmaceuticals Ltd
Outcome Of Board Of Directors Meeting- 14Thfebruary 2023
05:56 PM, 14th Feb 2023
In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Listing Regulations) we wish to inform you that the Board of Directors of the Company in their meeting held today i.e. Tuesday 14thFebruary 2023 at 03:30 pm and concluded at 05:30 pm inter-alia approved the following:a. Un-Audited Financial Results for the Quarter ended December 31 2022 along with Limited Review Report.b. Request received on 16th January 2023 from Mr. Dharam Chand Jain promoter of the company seeking reclassification of its name from Promoter and Promoter Group category to the Public category. Please find enclosed therewith the copies of the following:1. Un- audited Financial Results of the Company for the quarter ended 31st December 2022.2. Auditors Limited Review Report on the Un-audited Financial Results of the Company for the quarter ended 31st December2022.